HRTX

Heron Therapeutics (HRTX)

About Heron Therapeutics (HRTX)

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.

Details

Daily high
$1.89
Daily low
$1.82
Price at open
$1.85
52 Week High
$3.93
52 Week Low
$0.50
Market cap
282.1M
Dividend yield
0.00%
Volume
225,628
Avg. volume
2.0M
P/E ratio
-5.72

Heron Therapeutics News

Details

Daily high
$1.89
Daily low
$1.82
Price at open
$1.85
52 Week High
$3.93
52 Week Low
$0.50
Market cap
282.1M
Dividend yield
0.00%
Volume
225,628
Avg. volume
2.0M
P/E ratio
-5.72